Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CELC
CELC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CELC News
Boxer Capital Acquires $17.55 Million Stake in Corvus Pharmaceuticals
May 17 2026
Yahoo Finance
Celcuity Q1 2026 Earnings Call Insights
May 15 2026
seekingalpha
Celcuity Q1 Earnings Beat Expectations with Strategic Financial Outlook
May 14 2026
seekingalpha
Celcuity Updates on VIKTORIA-2 Clinical Trial Progress
May 14 2026
Newsfilter
ACT Capital Management Acquires New Position in Alumis Worth $4.36 Million
May 10 2026
Yahoo Finance
Middle East Tensions Weigh on Stock Market Performance
May 04 2026
NASDAQ.COM
Celcuity (CELC.US) Director Plans to Sell $3.52 Million in Common Stock via Form 144
May 04 2026
moomoo
Amazon Launches Supply Chain Services, Pressuring Logistics Stocks
May 04 2026
CNBC
US Stock Market Volatility Amid Oil Price Recovery
May 04 2026
NASDAQ.COM
Celcuity Upgraded to Buy with Price Target Raised to $165
May 04 2026
stocktwits
Celcuity's Phase 3 Trial Significantly Improves Survival in Breast Cancer
May 04 2026
NASDAQ.COM
Celcuity's Cancer Drug Study Shows Positive Results
May 02 2026
stocktwits
Celcuity Reports Positive Results from VIKTORIA-1 Clinical Trial
May 01 2026
Newsfilter
Celcuity Stock Rises Following Analyst Coverage Initiation
Apr 27 2026
Fool
Celcuity's Drug Nears FDA Review Approval
Apr 27 2026
NASDAQ.COM
Celcuity Reports Final 2025 Financial Results with Narrower Loss
Mar 27 2026
Fool
Show More News
